Mainz, Rheinland-Pfalz, Germany The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Mainz.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are KfW, EMBL Ventures.
Among the various public portfolio startups of the fund, we may underline ELARA Pharmaceuticals Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany.
The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2009. The fund is constantly included in less than 2 deals per year.
Funds with similar focus
| Fund Name | Location |
| Alamo Angels | San Antonio, Texas, United States |
| AltaVista | California, Pasadena, United States |
| Asobi System | Harajuku, Japan, Kantō |
| China Innovation Venture Partners | - |
| Feibo | - |
| JD Digital Assets | - |
| Mast Capital Management | Boston, Massachusetts, United States |
| Pappajohn Capital Resources | Des Moines, Iowa, United States |
| Qingruijuxin Investment Fund | Beijing, Beijing, China |
| Tsinghua AI Fund | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ELARA Pharmaceuticals | $6M | 26 Nov 2009 | Baden-Württemberg |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ELARA Pharmaceuticals | $6M | 26 Nov 2009 | Baden-Württemberg |
